Business DiversificationPfizer has diversified its business into new fields like oncology, internal medicine, rare diseases, immunology, vaccines, and hospitals to offset impacts from the weak demand in COVID-related products.
Financial PerformancePfizer reported a 2Q beat & raise and provided bullish comments on future COGS efficiencies.
Guidance And GrowthPfizer plans to launch non-COVID products in order to drive long-term revenue and profit growth.